Castleark Management LLC Axogen, Inc. Transaction History

Castleark Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$17.09 - $38.25 $1.98 Million - $4.43 Million	-115,901 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$34.05 - $55.9 $4.23 Million - $6.94 Million	-124,094 Reduced 51.71%	115,901 $4.27 Million
Q2 2018 Aug 15, 2018	SELL	$36.15 - $52.5 $1.99 Million - $2.89 Million	-55,093 Reduced 18.67%	239,995 $12.1 Million
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $1.67 Million - $2.76 Million	-68,556 Reduced 18.85%	295,088 $10.8 Million
Q4 2017 Feb 15, 2018	SELL	$18.5 - $28.6 $821,344 - $1.27 Million	-44,397 Reduced 10.88%	363,644 $10.3 Million
Q3 2017 Nov 15, 2017	BUY	$14.65 - $19.35 $5.98 Million - $7.9 Million	408,041	408,041 $7.9 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $681M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.